Process for the preparation of substituted pyrimidine derivatives

US9079884B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9079884-B2
Application numberUS-201314076955-A
CountryUS
Kind codeB2
Filing dateNov 11, 2013
Priority dateJun 30, 2008
Publication dateJul 14, 2015
Grant dateJul 14, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention is directed to processes for the preparation of substituted pyrimidine derivatives, useful as intermediates in the synthesis of histamine H 4 receptor modulators, and to intermediates in H4 modulator synthesis.

First claim

Opening claim text (preview).

We claim: 1. A compound of formula (XII) wherein PG 3 is a nitrogen protecting group selected from the group consisting of: —C(O)O—C(CH 3 ) 3 , —C(O)—CH 3 and —C(O)O—CH 2 CH 3 ; L 1 is CN; R c is selected from the group consisting of H, methyl, ethyl, propyl, isopropyl, —CF 3 , cyclopropyl, and cyclobutyl; R 8 is selected from the group consisting of hydrogen and C 1-4 alkyl; Z is selected from the group consisting of N and CH; n is 1 or 2; R 9 , R 10 and R 11 are each independently selected from the group consisting of hydrogen and C 1-4 alkyl; or a pharmaceutically acceptable salts thereof. 2. A compound as in claim 1 , wherein the compound of formula (XII) is a compound of formula (XII-S) or a pharmaceutically acceptable salt thereof. 3. A compound as in claim 2 , wherein PG 3 is selected from the group consisting of —C(O)OCH 2 CH 3 and —C(O)OC(CH 3 ) 3 .

Assignees

Inventors

Classifications

  • Drugs for immunological or allergic disorders · CPC title

  • C07D401/12Primary

    linked by a chain containing hetero atoms as chain links · CPC title

  • containing at least two amino groups bound to the carbon skeleton · CPC title

  • with hydrocarbon radicals, substituted by nitrogen atoms · CPC title

  • of an unsaturated carbon skeleton containing at least one six-membered aromatic ring · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9079884B2 cover?
The present invention is directed to processes for the preparation of substituted pyrimidine derivatives, useful as intermediates in the synthesis of histamine H 4 receptor modulators, and to intermediates in H4 modulator synthesis.
Who is the assignee on this patent?
Janssen Pharmaceutica Nv
What technology area does this patent fall under?
Primary CPC classification C07D401/12. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).